GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Tekla Healthcare Opportunities Fund (NYSE:THQ) » Definitions » Piotroski F-Score

Tekla Healthcare Opportunities Fund (Tekla Healthcare Opportunities Fund) Piotroski F-Score : 7 (As of May. 12, 2024)


View and export this data going back to . Start your Free Trial

What is Tekla Healthcare Opportunities Fund Piotroski F-Score?

Good Sign:

Piotroski F-Score is 7, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Tekla Healthcare Opportunities Fund has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for Tekla Healthcare Opportunities Fund's Piotroski F-Score or its related term are showing as below:

THQ' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 5   Max: 8
Current: 7

During the past 7 years, the highest Piotroski F-Score of Tekla Healthcare Opportunities Fund was 8. The lowest was 3. And the median was 5.


Tekla Healthcare Opportunities Fund Piotroski F-Score Historical Data

The historical data trend for Tekla Healthcare Opportunities Fund's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tekla Healthcare Opportunities Fund Piotroski F-Score Chart

Tekla Healthcare Opportunities Fund Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Piotroski F-Score
Get a 7-Day Free Trial 3.00 5.00 8.00 4.00 7.00

Tekla Healthcare Opportunities Fund Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.00 - 4.00 - 7.00

Competitive Comparison of Tekla Healthcare Opportunities Fund's Piotroski F-Score

For the Asset Management subindustry, Tekla Healthcare Opportunities Fund's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tekla Healthcare Opportunities Fund's Piotroski F-Score Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Tekla Healthcare Opportunities Fund's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Tekla Healthcare Opportunities Fund's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep23) TTM:Last Year (Sep22) TTM:
Net Income was $52.79 Mil.
Cash Flow from Operations was $55.81 Mil.
Revenue was $54.68 Mil.
Average Total Assets from the begining of this year (Sep22)
to the end of this year (Sep23) was (1066.014 + 1062.061) / 2 = $1064.0375 Mil.
Total Assets at the begining of this year (Sep22) was $1,066.01 Mil.
Long-Term Debt & Capital Lease Obligation was $225.00 Mil.
Total Assets was $1,062.06 Mil.
Total Liabilities was $229.54 Mil.
Net Income was $-86.25 Mil.

Revenue was $-84.15 Mil.
Average Total Assets from the begining of last year (Sep21)
to the end of last year (Sep22) was (1240.411 + 1066.014) / 2 = $1153.2125 Mil.
Total Assets at the begining of last year (Sep21) was $1,240.41 Mil.
Long-Term Debt & Capital Lease Obligation was $225.00 Mil.
Total Assets was $1,066.01 Mil.
Total Liabilities was $230.45 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Tekla Healthcare Opportunities Fund's current Net Income (TTM) was 52.79. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Tekla Healthcare Opportunities Fund's current Cash Flow from Operations (TTM) was 55.81. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Sep22)
=52.786/1066.014
=0.04951717

ROA (Last Year)=Net Income/Total Assets (Sep21)
=-86.252/1240.411
=-0.06953502

Tekla Healthcare Opportunities Fund's return on assets of this year was 0.04951717. Tekla Healthcare Opportunities Fund's return on assets of last year was -0.06953502. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Tekla Healthcare Opportunities Fund's current Net Income (TTM) was 52.79. Tekla Healthcare Opportunities Fund's current Cash Flow from Operations (TTM) was 55.81. ==> 55.81 > 52.79 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Sep23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep22 to Sep23
=225/1064.0375
=0.21145871

Gearing (Last Year: Sep22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep21 to Sep22
=225/1153.2125
=0.19510715

Tekla Healthcare Opportunities Fund's gearing of this year was 0.21145871. Tekla Healthcare Opportunities Fund's gearing of last year was 0.19510715. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

* Note that for banks and insurance companies, there's no Total Current Assets and Total Current Liabilities reported. Thus, we use Total Assets and Total Liabilities to calculate current ratio for banks and insurance companies.

Current Ratio (This Year: Sep23)=Total Assets/Total Liabilities
=1062.061/229.538
=4.62695066

Current Ratio (Last Year: Sep22)=Total Assets/Total Liabilities
=1066.014/230.447
=4.62585323

Tekla Healthcare Opportunities Fund's current ratio of this year was 4.62695066. Tekla Healthcare Opportunities Fund's current ratio of last year was 4.62585323. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Tekla Healthcare Opportunities Fund's number of shares in issue this year was 41.239. Tekla Healthcare Opportunities Fund's number of shares in issue last year was 41.269. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

* Note that for banks and insurance companies, there's no Gross Profit reported. Thus, we use net income instead of gross profit and calculate Net Margin for this score.

Net Margin (This Year: TTM)=Net Income/Revenue
=52.786/54.684
=0.96529149

Net Margin (Last Year: TTM)=Net Income/Revenue
=-86.252/-84.151
=1.02496702

Tekla Healthcare Opportunities Fund's net margin of this year was 0.96529149. Tekla Healthcare Opportunities Fund's net margin of last year was 1.02496702. ==> Last year's net margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Sep22)
=54.684/1066.014
=0.05129764

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Sep21)
=-84.151/1240.411
=-0.06784122

Tekla Healthcare Opportunities Fund's asset turnover of this year was 0.05129764. Tekla Healthcare Opportunities Fund's asset turnover of last year was -0.06784122. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+0+1+1+0+1
=7

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Tekla Healthcare Opportunities Fund has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

Tekla Healthcare Opportunities Fund  (NYSE:THQ) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Tekla Healthcare Opportunities Fund Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Tekla Healthcare Opportunities Fund's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Tekla Healthcare Opportunities Fund (Tekla Healthcare Opportunities Fund) Business Description

Traded in Other Exchanges
N/A
Address
1900 Market Street, Suite 200, Philadelphia, PA, USA, 19103
Tekla Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. The fund's investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies in the healthcare industry (including equity securities, debt securities, and pooled investment vehicles). The fund invests in securities of public and private companies.
Executives
Bill Maher director 600 WEST BROADWAY, 30TH FL., SAN DIEGO CA 92101
Aberdeen Standard Investments Inc. other: Adviser 1900 MARKET ST., 2ND FLOOR, PHILADELPHIA PA 19103
Rose Dimartino director C/O ABRDN, 1900 MARKET STREET, PHILADELPHIA PA 19103
Jaclyn Marie Matsick other: Director of Adviser C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Marika Tooze other: Director of Adviser C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Todd Reit director C/O ABERDEEN STANDARD INVESTMENTS, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
James Joseph O'connor other: Director of Adviser C/O ABERDEEN STANDARD INVESTMENTS, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Lucia Sitar officer: VP and Chief Legal Officer 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Christian Pittard officer: President ONE BOW CHURCHYARD, LONDON X0 EC4M 9HH
Megan Kennedy officer: Secretary and Vice President 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Jennifer A Nichols other: Director of Adviser 1735 MARKET STREET, 37TH FLOOR, PHILADELPHIA PA 19103
Stephen Bird director 388 GREENWICH STREET, 17TH FLOOR, NEW YORK NY 10022
Joseph Andolina officer: Chief Compliance Officer & VP 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Alan R Goodson officer: Vice President 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Sharon Ferrari officer: Treasurer and CFO 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103

Tekla Healthcare Opportunities Fund (Tekla Healthcare Opportunities Fund) Headlines

From GuruFocus

Tekla Healthcare Opportunities Fund Paid Distribution

By Business Wire Business Wire 10-31-2022

Tekla Healthcare Opportunities Fund Paid Distribution

By Business Wire Business Wire 02-28-2023

Tekla Healthcare Opportunities Fund's Dividend Analysis

By GuruFocus Research 01-23-2024

Tekla Healthcare Opportunities Fund's Dividend Analysis

By GuruFocus Research 10-18-2023

Tekla Healthcare Opportunities Fund Paid Distribution

By Business Wire Business Wire 01-31-2023

Tekla Healthcare Opportunities Fund Declares Monthly Cash Distribution

By Business Wire Business Wire 08-10-2022